Page 696 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 696

Hemodialysis and Extracorporeal Blood Purification  683



                                                                   70
                                                                      (61.3)
                                           Liver                   60                      (57.9)
                                               G (3.6 mg/min)             spKt/V   1.6
                                                                   50

                                  Kd                               40
                               (166 mL/min)   Urea pool          BUN (mg/dl)
                                               V (31 L)            30               TAC  35.8 mg/dl


                                                                   20
                                               Kr (0.4 mL/min)             (14.0)
                                                                   10
                                           Kidney
                                                                        Td         Ti
                                                                    0
                               Single-pool, fixed-volume model       0      24     48     72     96
                         A                                       B              Time (h)
                        Fig. 29-1 A, Single-pool, fixed-volume kinetic model of the urea metabolism and representative modeled
                        kinetic parameters determined in a 33-kg dog on intermittent maintenance hemodialysis consuming
                        approximately 56 g of dietary protein. Urea is generated in the liver as the major end product of protein
                        metabolism. The urea generation rate, G (mg of urea/min), determines the accumulation of urea in the urea
                        pool with a volume, V (L). Its removal from the urea pool is determined by the continuous residual renal
                        clearance, Kr (mL/min), and intermittently by hemodialysis via the urea clearance of the dialyzer,
                        Kd (mL/min). B, Graphic illustration of a three-point BUN profile (before and after hemodialysis values in
                        parentheses) that can be fitted to the single-pool model in the right panel. With direct measurement of renal
                        and dialyzer urea clearances (Kr, Appendix, Equation 6 and Kd, Appendix, Equation 5, respectively), kinetic
                        modeling allows computation of the urea generation rate (G, Appendix, Equation 9), the urea distribution
                        volume (V, Appendix, Equation 10), and the time-average concentration of BUN (TAC, Appendix,
                        Equation 1). The dose of dialysis expressed as the fractional clearance of the urea distribution volume using
                        single-pool kinetics (spKt/V, Appendix, Equation 11) also can be calculated. T d is the duration of dialysis,
                        and Ti is the duration of the interdialytic interval. AUC is the area under the BUN versus the time curve
                        and can be estimated using a trapezoidal method or ideally calculated by fitting the changes in BUN to the
                        kinetic model.

            DIALYSIS ADEQUACY                                   recovery of renal function. Realistic outcomes for these
                                                                animals that are treated with hemodialysis vary depending
            The optimal outcome for animals with acute renal failure
                                                                on age, chronicity of the disease, comorbidities, and
            is survival until renal function has recovered, but second-
                                                                residual renal function. Appropriate markers for dialysis
            ary goals may vary qualitatively depending on the nature
                                                                adequacy include length of survival, owner perceived
            of the underlying disease. An optimal outcome addition-
                                                                quality of life (e.g., activity, social interaction, appetite),
            ally should promote physiologic and metabolic stability
                                                                elimination of uremic symptomatology (hypertension,
            to facilitate recovery and promote an acceptable quality
            of life while minimizing secondary injury to the    hyperphosphatemia, anemia), nutritional adequacy, and
            recovering kidneys or other organs (heart, lungs, gut,  elimination of dialysis-associated complications.
            brain). As an outcome, survival is multifactorial and  For both acute and chronic dialysis, survival is a diffi-
            predicated on the diversity of the underlying cause and  cult outcome parameter to correlate specifically to dialytic
                                                                interventions. Yet, despite these constraints, the kineti-
            comorbidities, in addition to the delivered therapy. As
                                                                cally modeled dose of dialysis (Kt/V) has been shown
            such, outcome assessment by survival alone may be
                                                                to correlate independently with survival as an outcome
            disassociated from recovery of renal function or adequate
                                                                    humans
            delivery of dialysis. 34,149  Consequently, more sensitive  in  73,106,120,124 undergoing  maintenance  hemodialy-
                                                                sis,          and it is likely to be linked similarly to
            and predictive outcome measures should be considered
                                                                the success of dialysis in animals. The empirical use
            for assessment of dialysis adequacy, including recovery
            of renal function, improvement of the systemic      of proven standards of dialysis adequacy and clinical expe-
            manifestations of uremia, and reduction of complications  rience in human patients are useful first approximations
            attending uremia or its therapy. 19                 for appropriate veterinary standards of dialysis adequacy
              Survival is the optimal outcome for animals with end-  until evidence-based standards are determined in
                                                                       34,59
                                                                animals.
            stage renal disease because there is no prospect for
   691   692   693   694   695   696   697   698   699   700   701